ADARx Pharmaceuticals, Inc. ADRX

Set alert

Price alert · ADRX

All alert types
15.80 USD +0.04 +0.27%

As of Nov 3, 12:56 PM ET

Bid
15.70 × 1
Ask
15.83 × 1
15.00 Day range 16.46
15.76 52-week range 20.64
YTD
-18.33%
1 year
-18.33%
Open
15.78
Prev close
15.76
Mkt cap
1.75B
Vol
186.20K
Avg vol
691.66K
EPS
-1.16
P/E
0.00
Div yield
0.00%
More statistics
Low
15.00
High
16.46
Forward P/E
-10.42
Beta
0.00
Short ratio
2.00
Inst. own
46.02%
Dividend
0.00
Ex-div date
50-d avg
18.21
200-d avg
18.21
1y target
34.25

6M chart

Chart tools
Interval

Events in this range
  • Oct 20, 2026Rating: Morgan Stanley · — → Overweight
  • Oct 20, 2026Rating: UBS · — → Buy
  • Oct 20, 2026Rating: JP Morgan · — → Overweight
  • Oct 20, 2026Rating: TD Cowen · — → Buy
Signals (1)
NameDateAgo
RSI: OversoldNov 2, 20261 day ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 34.25 +116.7% upside
Target (low)
32.00
Target (mean)
34.25
Target (high)
38.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ADRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.36348-0.53 – -0.253670.000.0%2.58M0.0%3
Next quarter-0.37861-0.40 – -0.363630.000.0%2.58M0.0%3
Current year-1.68-1.89 – -1.550.000.0%5.94M0.0%3
Next year-1.51-1.81 – -1.18-1.68+9.9%39.87M+570.7%3

Upgrades and downgrades

The latest rating changes

ADRX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 20, 2026TD CowenInitiated—Buy
Oct 20, 2026JP MorganInitiated—Overweight
Oct 20, 2026UBSInitiated—Buy
Oct 20, 2026Morgan StanleyInitiated—Overweight